DCGO
DocGo Inc.NASDAQHealthcare$0.57+0.26%ClosedMarket Cap: $56.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.39
P/S
0.17
EV/EBITDA
710526.84
DCF Value
$1,407,809.14
FCF Yield
49.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
25.8%
Operating Margin
-27.7%
Net Margin
-56.6%
ROE
-71.4%
ROA
-0.0%
ROIC
0.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $74.9M | 11.6% | $-15.7M | $-134.1M | $-1.37 | — |
| FY 2025 | $322.2M | 25.8% | $-89.2M | $-182.4M | $-1.84 | — |
| Q3 2025 | $70.8M | 25.6% | $-42.0M | $-27.8M | $-0.28 | — |
| Q2 2025 | $80.4M | 31.6% | $-17.5M | $-11.2M | $-0.11 | — |
| Q1 2025 | $96.0M | 32.1% | $-14.0M | $-9.4M | $-0.09 | — |
| Q4 2024 | $120.8M | 33.5% | $-7.5M | $-3.3M | $-0.03 | — |
| FY 2024 | $616.6M | 34.6% | $28.7M | $20.0M | $0.18 | — |
| Q3 2024 | $138.7M | 36.0% | $10.1M | $5.5M | $0.05 | — |
| Q2 2024 | $164.9M | 33.9% | $10.1M | $6.5M | $0.06 | — |
| Q1 2024 | $192.1M | 35.0% | $15.9M | $11.2M | $0.10 | — |
| Q4 2023 | $199.2M | 33.5% | $11.7M | $7.6M | $0.07 | — |
| FY 2023 | $624.3M | 31.3% | $15.1M | $6.9M | $0.06 | — |